AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

8 recruiting trials

for Acute Rejection of Renal Transplant

Daratumumab for Late Antibody-Mediated Rejection NCT07081126NA1 site๐Ÿ“ Martin University Hospital, Martin ยท Tests: Daratumumab (Subcutaneously), control group Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients NCT01531257n/a1 site๐Ÿ“ Chicago Northwestern University Multi Center Observation of Sentinel Skin Graft for Detecting Acute Rejection After Renal Transplantation NCT05600634n/a3 sites๐Ÿ“ Xi'an๐Ÿ“ Hangzhou๐Ÿ“ Hangzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: Skin allotransplantation Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection NCT05084768n/a1 site๐Ÿ“ Loma Linda Loma Linda University ยท Tests: Donor-derived cell-free DNA Platelet Aggregation in the Diagnosis of Acute Graft Rejection NCT07275541n/a1 site๐Ÿ“ Martin University Hospital, Martin Proteogenomic Monitoring and Assessment of Liver Transplant Recipients NCT01644903n/a1 site๐Ÿ“ Chicago Northwestern University A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications NCT04877288Phase 338 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Washington D.C. Bristol-Myers Squibb ยท Tests: Belatacept, Tacrolimus, Cyclosporine A, Mycophenolate Mofetil, Enteric Coated Mycophenolate Sodium TreaT-Assay: the New Frontier for the Diagnosis of Acute Rejection in Kidney Transplantation NCT06801262n/a1 site๐Ÿ“ Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy